WCN25-318 FELZARTAMAB DURABLY REDUCES DISEASE RELEVANT BIOMARKERS THROUGH TARGETING OF CD38+ PLASMA CELLS AND PLASMABLASTS, THE UPSTREAM DRIVERS OF IgA NEPHROPATHY (IgAN)
Lisa Kivman, Tabea Kräft, Julia Rauser, Rainer Boxhammer et autres
Results:We enrolled 84 patients, 30 (36%) males and 54 (64%) females.Median age at AAV onset was 49.5 (35; 57) years.Seventy-four (88%) patients were ANCA-positive.Seventeen (20%) patients were diagnosed with renal-limited AAV.Median Birmingham vasculitis activity score (BVAS v.3) at biopsy was 14.5 (12; …
us, de, gb (code pays fourni par la source)